Search for content, post, videos

Medivir recruits new Chief Medical Officer

chief medical officer
The new Chief Medical Officer, Pia Baumann's, role includes overall responsibility for the continued clinical development of the candidate drug fostroxacitabine bralpamide. She will be part of the company's management team and will take up her position on February 20, 2023. "Her experience in
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.